COVID-19: Vaccines and Therapeutics
A Food and Drug Administration advisory committee yesterday recommended the agency authorize emergency use of the Novavax COVID-19 vaccine for adults.
The COVID-19 virus can be especially dangerous for women during pregnancy. This podcast talks about why pregnant women are more prone to serious infections and what they can do to protect themselves and their babies.
The COVID-19 virus can be especially dangerous for women during pregnancy.
A virtual learning program helps people get “the right care, when they need it, close to home.
Pregnant women around the country faced uncertainty upon the arrival of COVID-19.
The Centers for Disease Control and Prevention today released updated guidance for clinicians treating COVID-19 in patients who received the Pfizer COVID-19 antiviral pill Paxlovid.
Pfizer’s COVID-19 vaccine booster for children under age 5 was 80.3% effective and well tolerated in a clinical trial.
The FDA Tuesday authorized a single booster dose for children in this age group.
The U.S. Postal Service has delivered about 350 million free at-home tests to households since January. On December 15, 2022, the Biden Administration announced its COVID-19 Winter Preparedness Plan. As part of this plan, free COVID-19 tests are once again available through www.COVIDTests.gov.
FDA today authorized a single booster dose for children 5-11 who completed the Pfizer vaccine primary series at least five months before.